Literature DB >> 6264840

Liquid chromatographic assay of ketoconazole.

F A Andrews, L R Peterson, W H Beggs, D Crankshaw, G A Sarosi.   

Abstract

A reverse-phase, high-pressure liquid chromatographic method for the rapid and quantitative determination of ketoconazole has been developed. Drug levels from 0.5 to 10 microgram/ml can be determined in either yeast nitrogen base medium or human serum by using an octadecylsilane column. A retention time of 4.9 +/- 0.1 min resulted when the drug was eluted from a column with 75% methanol-25% 0.02 M (pH 7.5) phosphate buffer at a flow rate of 2 ml/min. Optimum sensitivity was obtained at a wavelength of 231 nm.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264840      PMCID: PMC181366          DOI: 10.1128/AAC.19.1.110

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Assay of flucytosine and furosemide by high-pressure liquid chromatography.

Authors:  A D Blair; A W Forrey; B T Meijsen; R E Cutler
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

2.  Rapid determination of serum 5-fluorocytosine levels by high-performance liquid chromatography.

Authors:  R B Diasio; M E Wilburn; S Shadomy; A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

3.  Influence of antioxidants on the bioactivity of amphotericin B.

Authors:  F A Andrews; W H Beggs; G A Sarosi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

4.  The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole.

Authors:  F C Odds; L J Milne; J C Gentles; E H Ball
Journal:  J Antimicrob Chemother       Date:  1980-01       Impact factor: 5.790

5.  Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.

Authors:  J Heeres; L J Backx; J H Mostmans; J Van Cutsem
Journal:  J Med Chem       Date:  1979-08       Impact factor: 7.446

6.  Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.

Authors:  D Borelli; J L Bran; J Fuentes; R Legendre; E Leiderman; H B Levine; A Restrepo; D A Stevens
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

7.  Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole.

Authors:  H B Levine; J M Cobb
Journal:  Am Rev Respir Dis       Date:  1978-10

8.  Quantitation of amphotericin B with use of high-pressure liquid chromatography.

Authors:  I Nilsson-Ehle; T T Yoshikawa; J E Edwards; M C Schotz; L B Guze
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

  8 in total
  6 in total

1.  High-pressure liquid chromatographic assay of Bay n 7133 in human serum.

Authors:  C E Fasching; C E Hughes; R F Hector; L R Peterson
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

2.  Pharmacokinetics of ketoconazole in patients with neoplastic diseases.

Authors:  A W Maksymiuk; H B Levine; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

5.  In vitro analysis of the interaction between sucralfate and ketoconazole.

Authors:  J D Hoeschele; A K Roy; V L Pecoraro; P L Carver
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

6.  Simplified bioassay method for measurement of flucytosine or ketoconazole.

Authors:  C A Bodet; J H Jorgensen; D J Drutz
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.